Megan Klupshas
Nurse Practitioner · Plainfield, ILNPI 1033488762
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $917, 3.0 times the $302 reported in 2021. Among nurse practitioner clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 131 payments — averaging $22.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$462
- AbbVie$411
- Lilly USA, LLC$344
- Electromed, Inc.$249
- Novo Nordisk$221
- Otsuka America Pharmaceutical, Inc.$210
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,971100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 18 | $462 |
| AbbVie | 20 | $411 |
| Lilly USA, LLC | 19 | $344 |
| Electromed, Inc. | 2 | $249 |
| Novo Nordisk | 11 | $221 |
| Otsuka America Pharmaceutical, Inc. | 9 | $210 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $141 |
| Astellas Pharma US Inc | 2 | $138 |
| Bayer | 7 | $114 |
| Exact Sciences | 4 | $84 |
| Boehringer Ingelheim | 4 | $80 |
| Upsher-smith Laboratories LLC | 3 | $65 |
| Neurocrine Biosciences, Inc. | 2 | $64 |
| IBSA Pharma Inc. | 3 | $54 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $51 |
| Lundbeck LLC | 2 | $48 |
| Nestle Healthcare Nutrition Inc. | 4 | $46 |
| Phadia US Inc. | 3 | $44 |
| Pfizer | 1 | $31 |
| Amgen | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $19 |
| AstraZeneca | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,971 in reported general payments places this provider in the 90th percentile of 4,869 nurse practitioner providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 17 | $12,429 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 21 | $10,114 |
| JardianceEmpagliflozin | 17 | $9,521 |
| JanuviaSitagliptin Phosphate | 17 | $9,416 |
| MyrbetriqMirabegron | 11 | $8,086 |
| Ondansetron OdtOndansetron | 12 | $1,109 |
| Celecoxib | 27 | $858 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $732 |
| Levothyroxine Sodium | 82 | $631 |
| Duloxetine Hcl | 14 | $584 |
| Gabapentin | 31 | $563 |
| Liothyronine Sodium | 29 | $552 |
| Atorvastatin Calcium | 34 | $540 |
| Bupropion XlBupropion Hcl | 17 | $340 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $234 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $462 | $12,42917 claims |
| Boehringer IngelheimJardiance | $80 | $9,52117 claims |
| Astellas Pharma US IncMyrbetriq | $138 | $8,08611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,869 nurse practitioner providers in Illinois.
Other nurse practitioner in Plainfield
- Deepa VallikatWest Dundee$332K
- Maria MalotoNaperville$135K
- Valerie LaroyOak Lawn$112K
- Jennifer LiebChampaign$109K
- Tanya MungerRockford$106K
- Erika VuckoChicago$76K
- Yvonna OldakerFlossmoor$74K
- Heather PiercePekin$72K
- Dara McKinleyEvanston$66K
- Kristine WarnesNaperville$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.